Atrás
Precio Infant Bacterial Therapeutics AB (publ) (IFTBF)
Gráfico del Precio de Acciones IFTBF
IFTBF Ganando
Infant Bacterial Therapeutics AB (publ)
$5.47
14.43%
$0.68
Al cierre: Jan 16, 16:00:00 GMT-5
$5.47
0%
$0
Mercado Posterior: Jan 16, 20:00:00 GMT-5
Estadísticas clave
Cierre Anterior
$4.78
Precio de apertura
$5.47
Rango del día
$5.47 - $5.47
Rango de 52 semanas
$4.78 - $8.2
Volumen
--
Volumen promedio
1.0K
EPS (TTM)
--
Rendimiento de dividendos
--
Cap. de mercado
--
¿Qué es INFANT BACTERIAL THERAPEUTICS A?
Infant Bacterial Therapeutics AB is a clinical stage pharmaceutical company, which engages in the development of drugs for the treatment of rare diseases affecting premature infants. The company is headquartered in Stockholm, Stockholm and currently employs 10 full-time employees. The company went IPO on 2016-03-29. The firm develops drugs that meet the needs of the premature infant. The Company’s focus is on clinical development of IBP-9414, a drug candidate containing Lactobacillus reuteri, in the prevention of necrotizing enterocolitis (NEC), a fatal disease that affects premature infants.
Características
Estrategias de Trading
© 2025 Finture Development Limited. All rights reserved